130 related articles for article (PubMed ID: 35609854)
1. Excess fructose enhances oleatic cytotoxicity via reactive oxygen species production and causes necroptosis in hepatocytes.
Kanazawa J; Kakisaka K; Suzuki Y; Yonezawa T; Abe H; Wang T; Takikawa Y
J Nutr Biochem; 2022 Sep; 107():109052. PubMed ID: 35609854
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
3. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
[TBL] [Abstract][Full Text] [Related]
5. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
[TBL] [Abstract][Full Text] [Related]
6. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
[TBL] [Abstract][Full Text] [Related]
7. The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.
Chen H; McKeen T; Chao X; Chen A; Deng F; Jaeschke H; Ding WX; Ni HM
Int J Biol Sci; 2022; 18(3):1096-1106. PubMed ID: 35173541
[TBL] [Abstract][Full Text] [Related]
8. Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through β-catenin/Foxo1/TLR4 signaling.
Qian LL; Ji JJ; Jiang Y; Guo JQ; Wu Y; Yang Z; Ma GS; Yao YY
FASEB J; 2022 May; 36(5):e22316. PubMed ID: 35429042
[TBL] [Abstract][Full Text] [Related]
9. Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model.
Ohene-Marfo P; Nguyen HVM; Mohammed S; Thadathil N; Tran A; Nicklas EH; Wang D; Selvarani R; Farriester JW; Varshney R; Kinter M; Richardson A; Rudolph MC; Deepa SS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474061
[TBL] [Abstract][Full Text] [Related]
10. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
11. Receptor-interacting protein 1 and 3 kinase activity are required for high-fat diet induced liver injury in mice.
Wu X; Arya RK; Huang E; McMullen MR; Nagy LE
Front Endocrinol (Lausanne); 2023; 14():1267996. PubMed ID: 38161978
[TBL] [Abstract][Full Text] [Related]
12. Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis.
Park J; Rah SY; An HS; Lee JY; Roh GS; Ryter SW; Park JW; Yang CH; Surh YJ; Kim UH; Chung HT; Joe Y
Metabolism; 2023 Apr; 141():155516. PubMed ID: 36773805
[TBL] [Abstract][Full Text] [Related]
13. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.
Roychowdhury S; McCullough RL; Sanz-Garcia C; Saikia P; Alkhouri N; Matloob A; Pollard KA; McMullen MR; Croniger CM; Nagy LE
Hepatology; 2016 Nov; 64(5):1518-1533. PubMed ID: 27301788
[TBL] [Abstract][Full Text] [Related]
14. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
15. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
16. A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.
Moro T; Nakao S; Sumiyoshi H; Ishii T; Miyazawa M; Ishii N; Sato T; Iida Y; Okada Y; Tanaka M; Hayashi H; Ueha S; Matsushima K; Inagaki Y
PLoS One; 2016; 11(1):e0146592. PubMed ID: 26745268
[TBL] [Abstract][Full Text] [Related]
17. TNF
Yang F; Shang L; Wang S; Liu Y; Ren H; Zhu W; Shi X
Oxid Med Cell Longev; 2019; 2019():2301903. PubMed ID: 31214277
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.
Assante G; Chandrasekaran S; Ng S; Tourna A; Chung CH; Isse KA; Banks JL; Soffientini U; Filippi C; Dhawan A; Liu M; Rozen SG; Hoare M; Campbell P; Ballard JWO; Turner N; Morris MJ; Chokshi S; Youngson NA
Genome Med; 2022 Jun; 14(1):67. PubMed ID: 35739588
[TBL] [Abstract][Full Text] [Related]
19. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis.
Tsurusaki S; Tsuchiya Y; Koumura T; Nakasone M; Sakamoto T; Matsuoka M; Imai H; Yuet-Yin Kok C; Okochi H; Nakano H; Miyajima A; Tanaka M
Cell Death Dis; 2019 Jun; 10(6):449. PubMed ID: 31209199
[TBL] [Abstract][Full Text] [Related]
20. Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis.
Mohammed S; Thadathil N; Ohene-Marfo P; Tran AL; Van Der Veldt M; Georgescu C; Oh S; Nicklas EH; Wang D; Haritha NH; Luo W; Janknecht R; Miller BF; Wren JD; Freeman WM; Deepa SS
Mol Cancer Res; 2023 Sep; 21(9):933-946. PubMed ID: 37204757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
